Related Experiment Video
Updated: May 31, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Prevalence of Drug-Resistant Mycobacterium tuberculosis in Rural Communities of Vhembe District, South Africa
M S Mashilo1, N T Banda1, V Mavumengwana2
1Department of Biochemistry and Microbiology, Faculty of Sciences, Engineering & Agriculture, University of Venda, Thohoyandou, South Africa.
Abstract:
Drug-resistant tuberculosis (DR-TB) is still a concern for public health and health security, making TB the world's largest cause of death from a single infectious agent. This Chapter was aimed at evaluating the prevalence of DR-MTB in rural communities of South Africa. A cross-sectional study in rural Vhembe District, South Africa, recruited 175 active TB patients. Data on lifestyle behaviour, socioeconomic, and environmental characteristics were collected via a questionnaire, and samples (blood and sputum) were collected. The U-rapid blood test confirmed HIV status. DNA was extracted from sputum and tested using multiplex real-time PCR assays with Anyplex and Allplex kits to detect Mycobacterium tuberculosis/nontuberculous mycobacteria, as well as DR-TB strains, respectively. The participants' ages ranged from 18 to 82 years (mean = 44 ± 13.0), with the majority being males (57.1%, 100/175) and unemployed (61.1%, 107/175). The co-infections detected include NTM and HIV. The prevalence of DR-MTB was 2.3% (4/175). A 20.6% (36/175) success rate was achieved in treatment outcomes. DR-TB remains low and is effectively managed, with favourable treatment outcomes reflecting effective clinical and public health interventions. However, the high prevalence of emerging NTM and HIV infections may compromise these gains, posing a potential threat to sustained TB control.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Mechanism of Antibiotic Resistance in MRSA
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Clinical Significance of Antibiotic Resistance